ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2017 American Transplant Congress

    Uromodulin and Toll-Like Receptor 4 Levels Predict Susceptibility to Bacterial Urinary Tract Infection After Renal Transplantation.

    K. Stahl,1 H. Lührs,1 J. Schmitz,2 I. Scheffner,1 W. Gwinner,1 J. Bräsen,2 H. Haller,1 M. Schiffer.1

    1Internal Medicine, Nephrology, Hannover Medical School, Hannover, Germany; 2Pathology, Hannover Medical School, Hannover, Germany

    Background: Urinary tract infection (UTI) remains the most common bacterial infection after kidney transplantation (kTx) and is associated with reduced allograft function as well as…
  • 2017 American Transplant Congress

    Risk Factors for Cryptococcal Disease in Transplant as Compared with Non-Transplant Patients: A Single Center Study.

    O. Beaird,1 O. Garner,2 R. Humphries,2 J. Schaenman.1

    1David Geffen School of Medicine at UCLA, Los Angeles, CA; 2UCLA Pathology & Laboratory Medicine, Los Angeles, CA

    Purpose: To examine clinical characteristics of non-HIV, immunocompromised patients diagnosed with cryptococcal disease, including solid-organ transplant (SOT) recipients.Methods: We performed retrospective chart review of non-HIV,…
  • 2017 American Transplant Congress

    Proteasome Modulation an Effective Strategy to Ameliorate Steatotic Liver Grafts Viability After Preservation.

    M. Zaouali,1 A. Panisello Roselló,1 T. Carbonell,2 A. Garcia-Gil,3 A. Lopez,4 R. Adam,4 J. Rosello-Catafau.1

    1Patología Experimental, Instituto de Investigaciones Biomédicas de Barcelona, CSIC, Barcelona, Spain; 2Phisiology, Fac. of Biology, Universitat de Barcelona, Barcelona, Spain; 3Transplantation, Hospital Clínico, Zaragoza, Spain; 4Hepato- Biliare Unit, Hôpital Paul Brousse, INSERM U-776, Université Paris Sud, Paris, France

    Recently we provided evidence for a possible protective role of proteasome inhibition during liver graft preservation. Although, several reported data confirmed that the proteolytic activity…
  • 2017 American Transplant Congress

    Outcomes of Renal Disease Related to Monoclonal Gammopathy After Kidney Transplantation: A Single Center Experience.

    T. Kaur, E. Poggio, S. Nurko.

    Nephrology, Cleveland Clinic, Cleveland

    Kidneys are commonly involved in patients with monoclonal gammopathies (MG). However, the role of kidney transplants (KTx) in MG still needs to be more clearly…
  • 2017 American Transplant Congress

    The Adoption of Generic Immunosuppressant Medications Among Kidney and Liver Transplant Recipients Using the Colorado All Payer Claims Database.

    Q. Liu,1 A. Smith,1 J. Park,2 M. Oguntimein,3 S. Dutcher,3 G. Bello,1 M. Helmuth,1 M. Turenne,1 R. Balkrishnan,4 M. Fava,1 P. Sharma,2 C. Beil,1 A. Leichtman,1 J. Zee.1

    1Arbor Research Collaborative for Health, Ann Arbor, MI; 2U of Michigan, Ann Arbor, MI; 3Food and Drug Administration, Silver Spring, MD; 4U of Virginia, Charlottesville, VA

    Background: Substitution of generic for brand-name immunosuppressants has increased in solid organ transplantation following the expiration of brand patents. Our aim was to describe the…
  • 2017 American Transplant Congress

    Does Choice of Induction Agent Affect Outcomes in Kidney Transplants from Deceased Donors with Acute Kidney Injury and Prolonged Cold Ischemia Time?

    G. Dube, S. Mohan, M. Chiles.

    Nephrology, Columbia University Medical Center, New York, NY

    Kidneys with acute kidney injury (AKI) have a higher rate of DGF but similar outcomes to kidneys without AKI, although most data are with kidneys…
  • 2017 American Transplant Congress

    Early Rejection in the Elderly: Is It Predictable?

    J. Clark, T. Sparkes, B. Masters, S. Jonchhe, A. Haririan, B. Thomas, B. Ravichandran.

    University of Maryland Medical Center, Baltimore, MD

    Introduction: Optimal induction for elderly kidney transplant recipients (KTR) remains unclear. Older age may be associated with decreased immunogenicity; however, clinical heterogeneity of the elderly…
  • 2017 American Transplant Congress

    Lactate Level Immediate Post-Liver Transplantation Is a Predictor of Early Allograft Dysfunction.

    K. Takahashi,1,2 S. Nagai,1 M. Safwan,1 K. Putchakayala,1 K. Collins,1 M. Rizzari,1 A. Yoshida,1 M. Abouljoud,1 S.-M. Jafri.3

    1Transplant and Hepatobiliary Surgery, Henry Ford Hospital, Detroit, MI; 2Surgery, University of Tsukuba, Tsukuba, Ibaraki, Japan; 3Gastroenterology, Henry Ford Hospital, Detroit, MI

    Background; Early allograft dysfunction (EAD) after liver transplantation (LT) is defined as a peak values of aminotransferase >2000 IU/mL during the first week or an…
  • 2017 American Transplant Congress

    Desensitization Regimen for the Patients with High Isoagglutinin Titers to Undergo Adult ABO-Incompatible Living Donor Liver Transplantation.

    W.-C. Lee, C.-F. Lee, T.-H. Wu, Y.-C. Wang, C.-H. Cheng, T.-J. Wu, H.-S. Chou, K.-M. Chan.

    Liver and Transplantation Surgery, Chang-Gung Memorial Hospital, Taoyuan, Taiwan

    Background: Adult living donor liver transplantation can be performed across ABO blood type barrier successfully by depleting B cells using rituximab. However, the patients with…
  • 2017 American Transplant Congress

    Reasons for Racial Disparities in Living Donor Liver Transplants (LDLT).

    M. McCauley,1 D. Goldberg,1 L. Nephew,1 R. Kalman,1 K. Forde.1

    1University of Pennsylvania, Philadelphia, PA; 2Albert Einstein Medical Center, Philadelphia, PA

    Introduction: End-stage liver disease patients who receive transplants from living donors have post-transplant outcomes as good or better than those transplanted with livers from deceased…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 181
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences